30 January 2025
Latham & Watkins Advises on Immunome’s Upsized Public Offering of Common Stock
Advising firms
Deal team
5 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Matt Bush Lead | Latham & Watkins LLP | Partner | capital markets | San Diego |
| Anthony Gostanian | Latham & Watkins LLP | Counsel | capital markets | Not stated |
| Julian Brody | Latham & Watkins LLP | Associate | capital markets | Not stated |
| Shelby Harrison | Latham & Watkins LLP | Associate | capital markets | Not stated |
| Sterling Swift | Latham & Watkins LLP | Associate | capital markets | Not stated |
2 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 150m (US$150 million)
- What the figure measures
- Issue size
- Client
- Not stated
- Counterparties
- Immunome, Inc. (Issuer)